• Return to Headlines

Neogenomics Inc Up 67.8% Since SmarTrend Uptrend Call (NEO)

By James Quinn

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 5 months, Neogenomics Inc has returned 67.78% as of today's recent price of $13.85.

Neogenomics Inc share prices have moved between a 52-week high of $14.61 and a 52-week low of $7.08 and are now trading 96% above that low price at $13.85 per share. Over the past week, the 200-day moving average (MA) has gone up 0.6% while the 50-day MA has advanced 2.9%.

NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Neogenomics Inc shares.

Log in and add Neogenomics Inc (NEO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights neogenomics inc

Ticker(s): NEO